𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The long-term prognosis of Guillain-Barré syndrome. Evaluation of prognostic factors including plasma exchange

✍ Scribed by C. A. Vedeler; E. Wik; H. Nyland

Book ID
109335632
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
448 KB
Volume
95
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term prognosis for Guillain-Barré s
Long-term prognosis for Guillain-Barré syndrome: Evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis
✍ Ben-Chung Cheng; Wen-Neng Chang; Jin-Bor Chen; Esther Chung-Yin Chee; Chi-Ren Hu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Sixty patients with Guillain-Barré syndrome (GBS), aged 16-83 years, have been identified over a period of 7 years. Of 60 patients, 30 received the double filtration plasmapheresis (DFP), 4 received intravenous immunoglobulin, and the other 26 received supportive care only. Therapeutic outcomes at 1

Electrophysiologic studies in the Guilla
Electrophysiologic studies in the Guillain–Barré syndrome: Effects of plasma exchange and antibody rebound
✍ S. Rudnicki; F. Vriesendorp; C. L. Koski; Dr. R. F. Mayer 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Nerve conduction studies (NCS) and antiperipheral nerve myelin antibody (A-PNM Ab) titers were measured serially in 29 patients with Guillain-Barr6 syndrome (GBS), of whom 21 were treated with plasmapheresis. Data were obtained from 3 to 6 days until 1 to 2 years after onset of symptoms. Within 3 to

Is there a scientific rationale for ther
Is there a scientific rationale for therapeutic plasma exchange or intravenous immune globulin in the treatment of acute guillain-barré syndrome?
✍ Robert Weinstein 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

## IMMUNE MODULATION AND PLASMA EXCHANGE Transferable Serum Factors In 1971, Stuart Cook and colleagues reported that sera from 26 of 31 patients with Guillain-Barre syndrome caused complement-dependent demyelination of living